The Swine Health Blackbelt Podcast - Dr. Troy Kaiser: PCV2 Immunization Innovations | Ep. 177

In this episode of The Swine Health Blackbelt Podcast, Dr. Troy Kaiser from Boehringer Ingelheim shares the latest on PCV2 immunization innovation and how shifting genotypes influence swine health protocols. He details safety and efficacy trials, label claims, and what this means for herd-level protection. Learn what’s next in immunization strategy and how to optimize immunity. Listen now on all major platforms! 

What will you learn:  

• PCV2 trends 

• Immunization efficacy testing 

• Cross-protection strategies 

• Safety profile standards 

• Label claim advancements 

Meet the guest: 

Dr. Troy Kaiser is a Principal Scientist and Clinical Project Lead & Laboratory Study Lead for livestock immunizers at Boehringer Ingelheim Animal Health, leading clinical studies for swine immunizer development. He earned his B.S. and M.S. from South Dakota State University, followed by his DVM. from Iowa State University. With decades of experience in swine virology, his work focuses on advancing the efficacy and safety of immunizers for PCV2. 
Connect with our guest on Social Media: LinkedIn 

Liked this one? Don’t stop now — Here’s what we think you’ll love: 

• Dr. Pablo Piñeyro: PCV4 & Co-infections | Ep. 139 
• Dr. Tyler Bauman: PRRS Control in Grow-Finish Pigs | Ep. 156